Quantitative immunohistochemical fingerprinting of adhesion/growth-regulatory galectins in salivary gland tumours: Divergent profiles with diagnostic potential

Histopathology

Volumn 58, Issue 4, 2011, Pages 543-556

  Remmelink, Myriam ^a   de Leval, Laurence ^b   Decaestecker, Christine ^a   Duray, Anaelle ^c   Crompot, Emerence ^c   Sirtaine, Nicolas ^d   André, Sabine ^e   Kaltner, Herbert ^e   Leroy, Xavier ^f   Gabius, Hans Joachim ^e   Saussez, Sven ^c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF MONS   (Belgium)

^d JULES BORDET INSTITUTE   (Belgium)

^e UNIVERSITY OF MUNICH   (Germany)

^f LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Diagnosis; Galectin; Immunohistochemistry; Salivary gland

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; GALECTIN 1; GALECTIN 3; GALECTIN 7; GALECTIN 8; POLYCLONAL ANTIBODY;

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND TUMOR; PAROTIDECTOMY; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SALIVARY GLAND CANCER; SALIVARY GLAND TUMOR; WARTHIN TUMOR;

ADENOCARCINOMA; ADENOMA, PLEOMORPHIC; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEOPLASM; CARCINOMA, ACINAR CELL; CARCINOMA, ADENOID CYSTIC; CARCINOMA, MUCOEPIDERMOID; DIAGNOSIS, DIFFERENTIAL; FEMALE; GALECTINS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79952721100     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03776.x     Document Type: Article

References (31)

1. Cooper DNW. Galectinomics: finding themes in complexity. Biochim. Biophys. Acta 2002; 1572; 209-231.
2. Schwartz-Albiez R. Inflammation and glycosciences. In Gabius H-J ed. The sugar code. Fundamentals of glycosciences. Weinheim: Wiley-VCH, 2009; 447-467.
3. Gabius H-J, Brehler R, Schauer A, Cramer F. Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas. Virchows Arch., B, Cell Pathol. 1986; 52; 107-115.
4. Lahm H, André S, Hoeflich A et al. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J. Cancer Res. Clin. Oncol. 2001; 127; 375-386.
5. Saussez S, Cucu DR, Decaestecker C et al. Galectin-7 (p53-induced gene-1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Ann. Surg. Oncol. 2006; 13; 999-1009.
6. Cada Z, Smetana K Jr, Lacina L et al. Immunohistochemical fingerprinting of the network of seven adhesion/growth-regulatory lectins in human skin and detection of distinct tumor-associated alterations. Folia Biol. 2009; 55; 145-152.
7. Xu XC, Sola Gallego JJ, Lotan R, El-Naggar AK. Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms. Int. J. Oncol. 2000; 17; 271-276.
8. Penner CR, Folpe AL, Budnick SD. C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod. Pathol. 2002; 15; 687-691.
9. Teymoortash A, Pientka A, Schrader C, Tiemann M, Werner JA. Expression of galectin-3 in adenoid cystic carcinoma of the head and neck and its relationship with distant metastasis. J. Cancer Res. Clin. Oncol. 2006; 132; 51-56.
10. Ferrazzo KL, Alves SM Jr, Santos E, Martins MT, de Sousa SM. Galectin-3 immunoprofile in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. Oral Oncol. 2007; 43; 580-585.
11. Ferrazzo KL, Neto MM, dos Santos E, dos Santos Pinto D, de Sousa SO. Differential expression of galectin-3, β-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. J. Oral Pathol. Med. 2009; 38; 701-707.
12. Nagy N, Legendre H, Engels O et al. Refined prognostic evaluation in colon cancer using immunohistochemical galectin fingerprinting. Cancer 2003; 97; 1849-1858.
13. Langbein S, Brade J, Badawi JK et al. Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Histopathology 2007; 51; 681-690.
14. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389; 300-305.
15. Bernerd F, Sarasin A, Magnaldo T. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc. Natl Acad. Sci. USA 1999; 96; 11329-11334.
16. Kopitz J, André S, von Reitzenstein C et al. Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene 2003; 22; 6277-6288.
17. Saussez S, Decaestecker C, Lorfevre F et al. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology 2008; 52; 483-493.
18. Cada Z, Chovanec M, Smetana K et al. Galectin-7: will the lectin's activity establish clinical correlations in head and neck squamous cell and basal cell carcinomas? Histol. Histopathol. 2009; 24; 41-48.
19. INK4a: modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J. 2007; 274; 3233-3256.
20. Lohr M, Kaltner H, Lensch M, André S, Sinowatz F, Gabius HJ. Cell-type-specific expression of murine multifunctional galectin-3 and its association with follicular atresia/luteolysis in contrast to pro-apoptotic galectins-1 and -7. Histochem. Cell Biol. 2008; 130; 567-581.
21. Saussez S, Decaestecker C, Mahillon V et al. Galectin-3 upregulation during tumor progression in head and neck cancer. Laryngoscope 2008; 118; 1583-1590.
22. Kopitz J, von Reitzenstein C, André S et al. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J. Biol. Chem. 2001; 276; 35917-35923.
23. 1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J. Biol. Chem. 2005; 280; 37266-37277.
24. Patsos G, André S, Roeckel N et al. Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile. Glycobiology 2009; 19; 726-734.
25. Gabius H-J (ed.). The sugar code. Fundamentals of glycosciences. Weinheim: Wiley-VCH, 2009.
26. Rotblat B, Niv H, André S, Kaltner H, Gabius HJ, Kloog Y. Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP. Cancer Res. 2004; 64; 3112-3118.
27. Wang JL, Gray RM, Haudek KC, Patterson RJ. Nucleocytoplasmic lectins. Biochim. Biophys. Acta 2004; 1673; 75-93.
28. Smetana K Jr, Dvoránková B, Chovanec M et al. Nuclear presence of adhesion/growth-regulatory galectins in normal/malignant cells of squamous epithelial origin. Histochem. Cell Biol. 2006; 125; 171-182.
29. Danguy A, Rorive S, Decaestecker C et al. Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system. Histol. Histopathol. 2001; 16; 861-868.
30. Cludts S, Decaestecker C, Mahillon V et al. Galectin-8 upregulation during hypopharyngeal and laryngeal tumor progression and comparison with galectins-1, -3, and -7. Anticancer Res. 2009; 29; 4933-4940.
31. Saussez S, de Leval L, Decaestecker C et al. Galectin fingerprinting in Warthin's tumors: lectin-based approach to trace its origin? Histol. Histopathol. 2010; 25; 541-550.